Genome engineering with CRISPR-Cas9 in the mosquito

Aedes aegypti
-Isolation of mutant alleles generated by non-homologous end joining or homology-directed repair
General considerations
-Work under RNAse free conditions! -Use clean nuclease-free filter tips, tubes, and other consumables -Wipe down benches and pipets with RNAse Away or RNaseZap before beginning work -Avoid excess freeze-thaw cycles for your mRNA and sgRNAs -Make small aliquots of each component and of the final injection mix and store at -80°C -We recommend designing and testing multiple sgRNAs to maximize the probability of achieving high levels of modification at your target -See our companion manuscript: bioRxiv for results and discussion of these techniques • NGG is the protospacer associated motif, or PAM, and is not contained within the sgRNA DNA template or transcribed RNA, but is required to be immediately adjacent to your target sequence in the genome for Cas9 nuclease activity -Putative target sites can be identified by simply scanning the region of the particular genomic location that you want to target (for example, the first exon of a given target gene) for a GG on either strand, or by using an online tool such as ZiFit (http://zifit.partners.org/ZiFiT/ChoiceMenu.aspx) or CRISPR Design (http://crispr.mit.edu). Each of these tools has pre-loaded the Aedes aegypti and Anopheles gambiae genome to assist in designing sgRNAs and predicting potential off-target binding and mutagenesis.
-Below is an example target region with CRISPR target sites highlighted in red, and the PAM highlighted in darker red:
• In the above example, the primary target sequences are listed below with the PAM indicated by bold italics:
-For this protocol, the sgRNA target sequence ideally starts with GG -these are the first two obligate nucleotides transcribed by the T7 RNA polymerase. If your target sequence does not start with GG, you may extend it to 21 or 22 base pairs (bp) (ie, add the 'GG' to the 5' end of your 20 bp recognition sequence). This advice does not apply if you're using a different amplification strategy (ie, expressing the sgRNA from a plasmid off of a U6 promoter, or using a different RNA polymerase)
• In the above example, the target sequences become the following, with added bases indicated by underlines:
-Target #1: GGATCGGCCCATCCCCACCAG CGG -Target #2: GGCATTTTCCGCTGGTGGGGAT GGG -Target #3: GGCATTTTCCGCTGGTGGGGA TGG -If you choose to scan for sites manually, you should still check your sgRNA design for potential offtarget effects by using ZiFit, CRISPR Design Tool, or another algorithm designed to predict off-target binding and mutagenesis.
-We try to avoid sgRNAs that have potential off-target sites with fewer than 3 mismatched bases (or fewer than 2 mismatched bases for a shorter, 17 bp guide).
sgRNA construct generation and RNA production -To generate the template for each sgRNA, order the following polyacrylamide gel-purified oligos from a vendor such as Integrated DNA Technologies (IDT)
• CRISPR_R: (this primer can be used for all targets)
5'-AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC-3'
• CRISPR_F: (contains the T7 promoter and the specific target sequence). 1. Run 2 µL of this reaction on a gel to verify the size and specificity of amplification 2. Purify the remaining 98µL with Ampure XP beads according to the following protocol. Alternatively, you can purify your template DNA by any method laid out in the MegaScript Kit handbook (e.g. PCR purification column, phenol/chloroform precipitation) a. Add 1.8x volume of Ampure XP beads to the PCR reaction in a 1.5 ml microcentrifuge tube b. Vortex to mix well c. Incubate for 5 min at room temperature d. Place on magnet stand until solution is clear; approximately 5 min e. Remove supernatant f. Rinse beads with 300 µL freshly made 80% ethanol (make with nuclease-free water) g. Remove supernatant and repeat rinse step h. Remove all remaining ethanol and air dry for 5 min i. Remove from magnet stand and resuspend in 30 µL of nuclease-free water. j. Incubate 10 min at room temperature and place on magnet stand k. Transfer supernatant to separate tube and check the concentration with a spectrophotometer. 3. Check the purity and concentration of your purified donor DNA with a spectrophotometer. A concentration of > 100 ng/µL is ideal, so that it will be concentrated enough for in vitro transcription. -Purify RNA using the MegaClear column purification kit following the manufacturer's protocol. You will obtain between 5-100 µg of total RNA from this reaction depending on template quality and incubation time.
-Check the concentration of RNA with a spectrophotometer, or better, check size and concentration with an Agilent Bioanalyzer or Tapestation. sgRNA should appear as a single band without obvious degradation products. The sizing is not always accurate due to the secondary structure of the sgRNAs, but the goal is to see a sharp peak at approximately the correct size with little evidence of degradation.
-Divide each sgRNA into 10µg or other conveniently sized aliquots and freeze at -80°C.
Choosing a source of Cas9
-We have obtained the best results when injecting recombinant Cas9 protein from PNA Bio (http://www.pnabio.com; catalog #CP01). In our hands and our system, it is more mutagenic and more stable than Cas9 mRNA, and much more mutagenic than injecting plasmids encoding Cas9. Although more efficient, it is also more expensive than supplying Cas9 as RNA or DNA.
- -To make Cas9 mRNA from pMLM3613:
1. Linearize 10 µg of plasmid with the restriction enzyme PmeI in a 50 µL reaction according to the following protocol. Mix reaction components well before incubation.
Restriction Digest Incubation
CutSmart buffer 5 µL 2 hours @ 37°C 2. Run 2 µL on a gel next to 400 ng of uncut plasmid to verify that digestion is complete 3. Purify remaining 48 µL of reaction with 1.8x Ampure XP beads (or perform sodium acetate precipitation as outlined in the mMessage mMachine T7 Ultra Protocol Handbook). Elute in 10 µL of nuclease-free water and check concentration by spectrophotometer. 4. Perform in vitro transcription using the Ambion mMessage mMachine T7 Ultra kit. Consult the protocol from the kit for full details. 5. Thaw NTP/CAP mix and 10x Reaction buffer; once thawed, keep the NTP/CAP mix on ice but the reaction buffer at room temperature. 6. Add the following, in order and mix gently but thoroughly by pipetting up and down: Donor plasmid or ssODN production for homologous recombination -Homologous recombination occurs at much lower frequency than non-homologous end-joiningmediated mutagenesis. Typical rates are 1-2% of G 0 (meaning 1 to 2 of 100 injected and outcrossed G 0 animals will give rise to mutant progeny containing the homologous recombination cassette)..
-Homology-directe repair templates can be double-stranded plasmid DNA or single-stranded oligonucleotides (ssODNs).
-If using double stranded DNA as a template for homology-directed repair, prepare the DNA via an endotoxin-free maxiprep prior to microinjection. We use the Qiagen EndoFree Plasmid Maxi Kit (Qiagen, catalog #12362).
-A good backbone for creating a dsDNA donor plasmid with a fluorescent marker is pSL1180-HRPUbECFP, available at Addgene (http://www.addgene.org/47917/) and described in Liesch et al., 2013 and McMeniman et al., 2014 or PSL1180polyUBdsRED (http://www.addgene.org/49327/) -Into this or a similar construct, insert homology arms of at least 500 bp on either side of the cut site.
The longer these arms, the better the efficiency of insertion. In general, we aim for ~2 kb of unique sequence on either side of the target recognition sequence -If using an oligonucleotide donor, the following guidelines apply:
-a ssODN donor is comprised of 200 bp total sequence due to the limits of commercially available oligo synthesis. We use IDT as an oligo synthesis provider -Homologous arms of at least 60 bp on either side are recommended, but the longer, the better.
-This limits the payload of a single-strand donor to 80 bp maximum, which can be used to deliver novel restriction sites (to aid in genotyping), STOP codons to ensure disruption of protein translation, an attP site, or LoxP sites as a framework for further site-directed engineering.
-We typically order oligos as Ultramers from IDT with standard desalting -no special purification is necessary -For both types of donors, ensure that your cassette does not contain the target recognition sequence to prevent CRISPR/Cas9-mediated editing of the donor cassette pre-or post-integration. Cas9 cleaves 3 bp 5' of the PAM; when designing ssODN donors, your arms should extend to this site.
-For a more detailed discussion of donor design for homologous recombination with other genome editing tools in Drosophila (but should translate to CRISPR), see Beumer et al., 2013 .
Final clean-up and injection
This step is critical to remove any leftover salt, ethanol, or other impurities from the various components.
- a. Carefully remove supernatant, taking care not to disrupt or dislodge the pellet b. Wash pellet by adding 100 µL of freshly made 70% ethanol c. Spin in a microcentrifuge at top speed for 3 min at 4°C d. Carefully remove supernatant, taking care not to disrupt or dislodge the pellet 6. Switch to a small pipet tip and carefully remove any remaining liquid 7. Air dry with lid open for a few min to allow residual ethanol to evaporate 8. Resuspend pellet in desired volume of nuclease-free water (accounting for the volume of protein that you'll need to add, if applicable!) 9. Add Cas9 recombinant protein if using, and mix thoroughly. 10. Proceed to microinjection immediately, or aliquot injection mix and freeze at -80°C
Screening for modification -We use Illumina's Miseq to quantify the cut-rate in G 0 animals via next-generation sequencing. This method reveals the levels of somatic modification in the injected individuals, which we believe represents a reasonable proxy for the likelihood of germline transmission.
1. Rear G 0 individuals to adults 2. Outcross in small pools (~5 G 0 individuals X ~10 wild-type animals of the opposite sex) 3. Blood-feed and collect eggs 4. Extract genomic DNA from the pools of injected G 0 animals 5. Prepare a 150-500 bp amplicon from this genomic DNA using primers on either side of the presumptive cut site. See "Preparing Sequencing Libraries" section for detailed methods 6. Assess the level of non-homologous end-joining-produced insertions and deletions by sequencing your amplicon with the Illumina Miseq -If modifications are detected at high rates, hatch eggs from the first outcross, and set up small sibling crosses of G 1 individuals or screen for fluorescence or another visible marker introduced by homologydirected repair.
-If screening for a visible marker, you need to outcross every surviving injected G 0 and screen every single offspring from these animals. Even when a G 0 is a successful founder, only a subset of their offspring will be positively marked.
-Blood-feed these G 1 families, collect eggs, and then examine genomic DNA from the G 1 parents for desired modifications, using methods outlined above, or screen for the presence of the dominant marker.
Preparing Sequencing Libraries
-We use the Illumina's Miseq platform to deep sequence pools of G 0 (or G 1 ) DNA.
-Sequencing libraries are generated via a two-step PCR. The first PCR will amplify a 100-500 bp amplicon surrounding the CRISPR site and add small overhangs to each end of this amplicon. These overhangs complement with Illumina's Nextera XT indexed primers, which you will use in the second PCR.
-Design and order primers:
1. Design primers that will generate a small amplicon of 100-500 bp surrounding your CRISPR target site. Design the amplicon so that the CRISPR site is about 75 bp (50-100 bp is OK) from one primer. 2. Test primer sets with wild-type DNA and KOD Hot Start Polymerase (or any other polymerase) 3. Select a primer set that amplifies a single band of the expected size and verify the sequence identity via Sanger sequencing. This is a good opportunity to ensure that the sgRNA binding site doesn't contain polymorphisms in your injection strain. 4. Once you have a primer set that amplifies the correct wild-type amplicon surrounding your CRISPR site, add overhangs to your custom primers. The primer around 75 bp from your CRISPR site will be used to create the "Miseq_F" primer. 
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! = ( ) 9. Load and run your qPCR plate. When the qPCR run is finished, the software will automatically create a standard curve and interpolate the molarity of your samples. The screen-shot below shows the results of a qPCR run -Make final pool 1. Dilute all pools to 10 nM based on the qPCR readings 2. Combine equal volumes of each 10 nM pool to create a final pool, which will be used for sequencing on the MiSeq.
